These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17202998)

  • 1. The pitfalls in the development of biologic therapy.
    Maini RN; Feldmann M
    Nat Clin Pract Rheumatol; 2007 Jan; 3(1):1. PubMed ID: 17202998
    [No Abstract]   [Full Text] [Related]  

  • 2. International guidelines on access to biologic therapy: why the differences and which is best?
    Deighton C; Hyrich K
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):520-1. PubMed ID: 18665149
    [No Abstract]   [Full Text] [Related]  

  • 3. Abatacept: new drug. Rheumatoid arthritis: after failure of TNF alpha antagonists and rituximab.
    Prescrire Int; 2008 Dec; 17(98):232. PubMed ID: 19422143
    [No Abstract]   [Full Text] [Related]  

  • 4. Small molecule challenges dominance of TNF-alpha inhibitors.
    Sheridan C
    Nat Biotechnol; 2008 Feb; 26(2):143-4. PubMed ID: 18259158
    [No Abstract]   [Full Text] [Related]  

  • 5. Economics of biological therapies.
    Kelly CJ; Mir FA
    BMJ; 2009 Aug; 339():b3276. PubMed ID: 19700510
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis.
    Franklin G; Greenspan J; Chen S
    Ann Clin Lab Sci; 2009; 39(2):192-5. PubMed ID: 19429808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
    Geraghty EM; Ristow B; Gordon SM; Aronowitz P
    Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bioLOGIC Europe 2007--Terrapinn's eighth annual conference.
    Mackay J
    IDrugs; 2007 Aug; 10(8):543-8. PubMed ID: 17665328
    [No Abstract]   [Full Text] [Related]  

  • 9. IL-1 trap go-ahead.
    Ratner M
    Nat Biotechnol; 2008 May; 26(5):485. PubMed ID: 18464767
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials.
    Gerlag DM; Tak PP
    Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):311-23. PubMed ID: 18455687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract]   [Full Text] [Related]  

  • 13. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy.
    Roos JC; Chilvers ER; Ostor AJ
    J Rheumatol; 2007 Jan; 34(1):238-9; author reply 239. PubMed ID: 17216703
    [No Abstract]   [Full Text] [Related]  

  • 14. Tysabri back on market.
    Sheridan C
    Nat Biotechnol; 2006 Aug; 24(8):874. PubMed ID: 16900111
    [No Abstract]   [Full Text] [Related]  

  • 15. Pericardial effusions on anti-TNF therapy for rheumatoid arthritis--a drug side effect or uncontrolled systemic disease?
    Edwards MH; Leak AM
    Rheumatology (Oxford); 2009 Mar; 48(3):316-7. PubMed ID: 19106166
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.
    Gonzalez-Gay MA; Garcia-Unzueta MT; Berja A; Vazquez-Rodriguez TR; Gonzalez-Juanatey C; de Matias JM; Martin J; Dessein PH; Llorca J
    Ann Rheum Dis; 2008 Nov; 67(11):1644-6. PubMed ID: 18854515
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging biological therapies in systemic lupus erythematosus.
    Mount GR; Gilliland WR
    Clin Pharmacol Ther; 2008 Jan; 83(1):167-71. PubMed ID: 18000515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
    Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical cutaneous tuberculosis in a patient with rheumatoid arthritis treated with infliximab.
    Asano Y; Kano Y; Shiohara T
    Acta Derm Venereol; 2008; 88(2):183-4. PubMed ID: 18311458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.